Search company, investor...

ProCure Treatment Centers

procure.com

Founded Year

2005

Stage

Unattributed | Alive

Total Raised

$215M

Last Raised

$14M | 4 yrs ago

About ProCure Treatment Centers

ProCure is a healthcare company that develops and operates full-service proton therapy centers. Procure provides a comprehensive approach to the design, constructiong, financing, staffing, training, and day-to-day operations of proton therapy centers.

Headquarters Location

420 North Walnut Street

Bloomington, Indiana, 47404,

United States

Missing: ProCure Treatment Centers's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ProCure Treatment Centers's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

ProCure Treatment Centers Patents

ProCure Treatment Centers has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/11/2008

12/1/2015

Anesthesia, Surgery, Medical terminology, Surgical removal procedures, Medical equipment

Grant

Application Date

9/11/2008

Grant Date

12/1/2015

Title

Related Topics

Anesthesia, Surgery, Medical terminology, Surgical removal procedures, Medical equipment

Status

Grant

Latest ProCure Treatment Centers News

ProCure Treatment Centers Raises $40M

Feb 1, 2011

ProCure Treatment Centers Raises $40M February 1, 2011 Bloomington, Indiana-based ProCure Treatment Centers has raised $40 million in private equity financing led by Maverick Capital. The funding will help ProCure develop and expand its network of proton therapy centers. Proton therapy is a form of radiation treatment and an alternative to standard X-ray radiation for patients with cancer and for some non-cancerous tumors. Previously, ProCure had raised more than $70 million from investors including McClendon Venture Company. PRESS RELEASE ProCure Treatment Centers, Inc. (ProCure), a privately held healthcare company that specializes in proton therapy, announced today that it completed a $40 million round of private equity financing led by Maverick Capital. The funding will support the continued development and expansion of ProCure’s network of proton therapy centers. ProCure is the only healthcare company in the world that has developed and is operating multiple proton centers. The $40 million financing follows two significant investments totaling over $70 million led by McClendon Venture Company, LLC (MVC). MVC is owned by Aubrey K. McClendon of Oklahoma City, Oklahoma. “We are extremely pleased to welcome Maverick Capital to the ProCure team,” said McClendon. “They are a highly respected private investment firm that invests in companies they expect to have strong growth potential. In the case of ProCure, like me, they also recognize the opportunity to change the way cancer care is delivered in local communities and make this proven technology available to more and more people.” “ProCure has emerged as the clear leader in the field of proton therapy and we are excited to join them in bringing this much needed technology to the market for cancer patients,” said Steve Kapp, Limited Partner, Maverick Capital. “The recent financing will be instrumental in continuing our mission to increase patients’ access to proton therapy. We are delighted to have a premiere group like Maverick Capital invest in our company. We have been very pleased to have the financial and business support of our existing and new investors. Bringing proton therapy into the community where most patients are treated for cancer is an extremely complex undertaking. It requires investors with experience and vision. We are very fortunate to have MVC and Maverick working with us,” said Hadley Ford, CEO of ProCure. Proton therapy is an advanced form of radiation treatment and an important alternative to standard X-ray radiation for many patients with cancer and for some non-cancerous tumors. Proton therapy has been shown to be beneficial in the treatment of a broad range of tumor types including brain, central nervous system, gastrointestinal, head and neck, lung and prostate as well as sarcomas and many pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors such as base of skull and tumors along the spinal cord. © 2015 Buyouts Insider / Argosy Group LLC

ProCure Treatment Centers Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ProCure Treatment Centers Rank

ProCure Treatment Centers Frequently Asked Questions (FAQ)

  • When was ProCure Treatment Centers founded?

    ProCure Treatment Centers was founded in 2005.

  • Where is ProCure Treatment Centers's headquarters?

    ProCure Treatment Centers's headquarters is located at 420 North Walnut Street, Bloomington.

  • What is ProCure Treatment Centers's latest funding round?

    ProCure Treatment Centers's latest funding round is Unattributed.

  • How much did ProCure Treatment Centers raise?

    ProCure Treatment Centers raised a total of $215M.

  • Who are the investors of ProCure Treatment Centers?

    Investors of ProCure Treatment Centers include Maverick Capital and McClendon Venture Company.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.